Related Experiment Videos
Studies on B-lymphocyte dysfunctions in severely burned patients
B Schlüter1, W König, M Köller
1Lehrstruhl für Med. Mikrobiologie und Immunologie, Arbeitsgruppe Infektabwehrmechanismen, Ruhr-Universität Bochum, F.R.G.
The Journal of Trauma
|November 1, 1990
Summary
Severe burns impair B-lymphocyte function, affecting immune responses. This study reveals suppressed B-cell proliferation and immunoglobulin production in burn patients, increasing infection risk.
Area of Science:
- Immunology
- Burn Injury Research
- Cellular Biology
Background:
- Severely burned patients exhibit increased susceptibility to infections and sepsis.
- The role of B-lymphocyte dysfunction in post-burn immune compromise requires further elucidation.
Purpose of the Study:
- To investigate in vitro functional parameters of peripheral blood B-lymphocytes in severely burned patients.
- To assess B-cell proliferation, immunoglobulin synthesis, and activation following burn injury.
Main Methods:
- Analysis of peripheral blood B-lymphocytes from 10 severely burned patients (25-72% TBSA).
- In vitro stimulation assays using Staphylococcus aureus strain Cowan I (SAC) and pokeweed mitogen (PWM).
- Measurement of immunoglobulin M (IgM) and G (IgG) synthesis, and CD23 surface antigen expression.
Main Results:
- B-cell numbers remained unchanged, but proliferation was suppressed between weeks 2-4 postburn.
- Immunoglobulin M (IgM) synthesis followed a similar suppression pattern, while Immunoglobulin G (IgG) production decreased throughout the monitored period.
- Interleukin 4-induced B-cell activation (CD23 expression) and soluble CD23 (sCD23) release were impaired from weeks 2-5 postburn.
Conclusions:
- B-lymphocyte activation, proliferation, and differentiation processes are significantly impaired following severe burn injury.
- This B-cell dysfunction may contribute to the heightened susceptibility to infection and sepsis observed in burn patients.
- Further research into immunomodulatory strategies could mitigate post-burn immune deficits.